169 related articles for article (PubMed ID: 7878289)
1. Cytokines as mediators of hypercalcemia of malignancy.
Pfeilschifter J
Recent Results Cancer Res; 1994; 137():1-19. PubMed ID: 7878289
[No Abstract] [Full Text] [Related]
2. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
Wysolmerski JJ; Broadus AE
Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cancer-induced hypercalcemia.
Rosol TJ; Capen CC
Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
5. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
Tai N; Inoue D
Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
[TBL] [Abstract][Full Text] [Related]
6. Cancer and hypercalcemia of malignancy: a change in focus.
Muggia F
Semin Oncol; 1991 Aug; 18(4 Suppl 5):1-2. PubMed ID: 1925623
[No Abstract] [Full Text] [Related]
7. In vivo models of hypercalcemia of malignancy.
Schilling T
Recent Results Cancer Res; 1994; 137():44-75. PubMed ID: 7878295
[No Abstract] [Full Text] [Related]
8. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
9. Humoral hypercalcemia of malignancy: role of parathyroid hormone-related protein.
Blind E
Recent Results Cancer Res; 1994; 137():20-43. PubMed ID: 7878294
[No Abstract] [Full Text] [Related]
10. Clinical picture of humoral hypercalcemia of malignancy.
Ziegler R
Recent Results Cancer Res; 1994; 137():107-13. PubMed ID: 7878290
[No Abstract] [Full Text] [Related]
11. [Treatment of malignancy associated hypercalcemia].
Tai N; Inoue D
Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
[TBL] [Abstract][Full Text] [Related]
12. Morphological characteristics of tumors with humoral hypercalcemia of malignancy: functional morphology of PTHrP.
Turzynski A; Baumgart S; Bauch B; Dietel M
Recent Results Cancer Res; 1994; 137():76-97. PubMed ID: 7878296
[No Abstract] [Full Text] [Related]
13. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
Raue F
Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
[No Abstract] [Full Text] [Related]
14. Hypercalcemia of malignancy: pathophysiology and treatment.
Adami S; Rossini M
Bone; 1992; 13 Suppl 1():S51-5. PubMed ID: 1581120
[TBL] [Abstract][Full Text] [Related]
15. Peptide mediators of hypercalcemia in malignancy.
Strewler GJ; Nissenson RA
Annu Rev Med; 1990; 41():35-44. PubMed ID: 2184736
[TBL] [Abstract][Full Text] [Related]
16. [Malignant hypercalcemia with and without bone metastasis].
Millán Núñez-Cortés J; de Moneo González A
Rev Clin Esp; 1996 Jun; 196(6):388-91. PubMed ID: 8767075
[No Abstract] [Full Text] [Related]
17. [Mechanism of tumor hypercalcemia].
Baglin A; Prinseau J
Ann Med Interne (Paris); 1993; 144(1):35-41. PubMed ID: 8503605
[No Abstract] [Full Text] [Related]
18. Hypercalcemia associated with hematologic malignancies.
Grauer A
Recent Results Cancer Res; 1994; 137():114-21. PubMed ID: 7878291
[No Abstract] [Full Text] [Related]
19. [Etiopathogenesis of paraneoplastic hypercalcemia].
Fontaine MA; Almer S; Franchimont P
Rev Med Liege; 1992 Jul; 47(7):347-56. PubMed ID: 1636076
[No Abstract] [Full Text] [Related]
20. Prostaglandins and hypercalcemia of cancer.
Robertson RP
Med Clin North Am; 1981 Jul; 65(4):845-53. PubMed ID: 7278429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
